Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas (BIOVES)
Feasibility Study for the Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Katia Scotlandi, MSc
- Phone Number: 39 051 6366760
- Email: katia.scotlandi@ior.it
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40136
- Recruiting
- Istituto ortopedico Rizzoli Laboratorio di Ricerc Oncologica e Genomica funzioanle
-
Contact:
- Katia Scotlandi, MSc
- Phone Number: 390516366760
- Email: katia.scotlandi@ior.it
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion criteria for cancer patients
- Male and female patients of any age diagnosed with Ewing sarcoma.
- Signed, study-specific informed consent form for the BIOVES study (cancer patients)
Inclusion criteria for non-cancer patients
- Male and female patients of legal age without a cancer diagnosis.
- Signed, study-specific informed consent form for the BIOVES study (non-cancer patients)
Exclusion Criteria:
Patients who do not meet all inclusion criteria
-
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
oncological subject
|
onco
|
|
non-oncological subjects
|
non onco
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
characterisation of circulating biomarkers
Time Frame: at baseline (time 0); before surgery; after 6 months from surgery
|
search for circulating biomarkers from blood samples taken at three different time points
|
at baseline (time 0); before surgery; after 6 months from surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BIOVES
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.